Risk of transient breathing difficulties in newborns of mothers on antidepressants

January 14, 2014

Infants of expectant mothers who take antidepressant drugs, known as selective serotonin reuptake inhibitors (SSRIs), during late pregnancy are at an increased risk for persistent pulmonary hypertension (high blood pressure in the lungs) finds a study published in BMJ today.

The authors stress that the risk is still low even in the context of SSRI exposure, but say pregnant women considering or using SSRIs and their families should be counselled about the condition and that it can typically be managed successfully if it does occur following SSRI exposure.

Decisions about treatment for depression during pregnancy must consider potential risks to both the mother and the . One potential adverse effect is persistent pulmonary hypertension of the newborn (PPHN) – in the lungs following birth leading to breathing difficulties. It is a rare condition, but can be severe when associated with other conditions.

Results from previous studies investigating a possible link between SSRI use in pregnancy and PPHN have been mixed, so researchers in Canada set out to summarise the data and help resolve these conflicting findings for clinicians.

They examined the results of seven studies reporting PPHN with antidepressant use during pregnancy. Analysis was only possible for SSRIs, due to a lack of data on other classes of antidepressants.

Differences in study design and quality – and several known for PPHN - were taken into account.

The results suggest a small but significantly for PPHN in infants exposed to SSRIs during . There was no evidence of an increased risk with exposure during early pregnancy.

However, the authors stress that the risk of PPHN remains low (is typically around two births per 1,000) and they estimate that 286 to 351 women would need to be treated with an SSRI in late pregnancy to see one additional case of PPHN.

To our knowledge, this is the first published meta-analysis to examine SSRI exposure and PPHN, say the authors.

Future research should determine if other classes of antidepressants show similar associations – and whether risk factors such as caesarean section, obesity, and preterm delivery, may also have an impact - in addition to the potential effects of clinical depression. They conclude depression during pregnancy must not be left untreated.

Explore further: Fetal NSAID exposure not tied to persistent pulmonary HTN

Related Stories

Fetal NSAID exposure not tied to persistent pulmonary HTN

December 3, 2012

(HealthDay)—There appears to be no association between persistent pulmonary hypertension of the newborn (PPHN) and gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, according to ...

Antidepressant use during pregnancy and high blood pressure

March 22, 2012

Use of selective serotonin re-uptake inhibitor (SSRI) antidepressants during pregnancy appears to be linked with increased risk of pregnancy induced high blood pressure ("hypertension"), but a causal link has not been established.

Recommended for you

Should more kids have their tonsils out?

January 17, 2017

(HealthDay)—Because of stringent tonsillectomy guidelines, some kids who could benefit from tonsil removal surgery aren't getting it, two new reviews suggest.

Teens unlikely to be harmed by moderate digital screen use

January 13, 2017

Parents and pediatricians alike may worry about the effects of teens' screen time, but new findings from over 120,000 adolescents in the UK indicate that the relationship between screen time and well-being is weak at best, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.